Literature DB >> 2374175

Expression of a human complementary DNA for the multidrug resistance gene in murine hematopoietic precursor cells with the use of retroviral gene transfer.

J R McLachlin1, M A Eglitis, K Ueda, P W Kantoff, I H Pastan, W F Anderson, M M Gottesman.   

Abstract

In multidrug resistance, cells become simultaneously resistant to anthracyclines, vinca alkaloids, epipodophyllotoxins, and certain other natural product cytotoxic drugs. Resistance results from synthesis of a multidrug transporter (P-glycoprotein) encoded by the MDR1 gene (also known as the PGY1 gene). In the present study, a retrovirus vector containing a complementary DNA for the human multidrug resistance gene HaMDR1/A was used to transfer the multidrug resistance phenotype to bone marrow cells of the DBA/2J mouse. A high proportion of transduced bone marrow cells showed resistance to both colchicine and vinblastine, as determined by in vitro colony formation of hematopoietic precursor cells. In addition, brief culturing of the cells in a cytotoxic drug following exposure to the retrovirus vector could be used to increase the proportion of bone marrow cell colonies that were resistant. These results may serve as a model for the generation and selection of bone marrow cells resistant to the toxic effects of chemotherapeutic agents in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2374175     DOI: 10.1093/jnci/82.15.1260

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  9 in total

Review 1.  Drug resistance in oncology: from concepts to applications.

Authors:  J L Cazin; P Gosselin; P Cappelaere; J Robert; A Demaille
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Adenovirus mediated-gene transfer into cardiomyocytes.

Authors:  L A Kirshenbaum
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

Review 3.  MDR gene transfer into live mice.

Authors:  C Richardson; M Ward; A Bank
Journal:  J Mol Med (Berl)       Date:  1995-04       Impact factor: 4.599

Review 4.  Cellular models for multiple drug resistance in cancer.

Authors:  M Clynes
Journal:  In Vitro Cell Dev Biol       Date:  1993-03

Review 5.  Human cancer and gene therapy.

Authors:  G Schmidt-Wolf; I G Schmidt-Wolf
Journal:  Ann Hematol       Date:  1994-12       Impact factor: 3.673

Review 6.  From laboratory expertise to clinical practice: multidrug-resistance-based gene therapy becomes available for urologists.

Authors:  G H Mickisch; F H Schroeder
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

Review 7.  P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells.

Authors:  T Licht; I Pastan; M Gottesman; F Herrmann
Journal:  Ann Hematol       Date:  1994-10       Impact factor: 3.673

8.  Proliferation of multipotent hematopoietic cells controlled by a truncated erythropoietin receptor transgene.

Authors:  S L Kirby; D N Cook; W Walton; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

9.  Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells.

Authors:  C Baum; S Hegewisch-Becker; H G Eckert; C Stocking; W Ostertag
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.